Dr. Daniel Amen shares his BRIGHTMINDS approach for preventing Alzheimer's, addressing 11 risk factors including blood flow, ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing.

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a ...

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved a label ...

A single, freely available, noninvasive brain scan done in just a few minutes during midlife can predict what chronic ...

People in early stages of the disease may show other signs of cognitive deterioration such as being unable to follow ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

UCLA Health researchers mapped four distinct pathways leading to Alzheimer’s disease using electronic health records.   The ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...